These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6605324)

  • 1. Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles.
    Chaplin DJ; Sheldon PW; Stratford IJ; Ahmed I; Adams GE
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Oct; 44(4):387-98. PubMed ID: 6605324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
    Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
    Denekamp J; Michael BD; Minchinton AI; Smithen CE; Stewart FA; Stratford MR; Terry NH
    Br J Cancer; 1982 Feb; 45(2):247-55. PubMed ID: 7059473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
    Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers.
    Shibamoto Y; Nishimoto S; Shimokawa K; Hisanaga Y; Zhou L; Wang J; Sasai K; Takahashi M; Abe M; Kagiya T
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1045-8. PubMed ID: 2703384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of new hypoxic cell sensitizers in vivo.
    Stone HB; Sinesi MS
    Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of basic 2-nitroimidazole radiosensitizers.
    Williams MV; Denekamp J; Minchinton AI; Stratford MR
    Br J Cancer; 1982 Jul; 46(1):127-37. PubMed ID: 7104192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization by SR-2508 plus Ro 03-8799.
    Stone HB; Luu YH; Lam KN
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1097-100. PubMed ID: 2943707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azomycin riboside: a new radiosensitizer.
    Pedersen JE; Barron G; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
    Brown JM; Yu NY; Workman P
    Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
    Cox JD; Byhardt RW; Komaki R; Greenberg M
    Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):37-40. PubMed ID: 6245044
    [No Abstract]   [Full Text] [Related]  

  • 20. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.